Ibuprofen is an NSAID (propionic acid derivative) indicated for pain, fever and inflammation. We supply it to US manufacturers of tablets, capsules and oral suspension.
Data from PubChem (CID 3672) and FDA’s substance registry
CAS number
15687-27-1
Molecular formula
C13H18O2
Molecular weight
206.3g/mol
FDA UNII
IUPAC name
2-[4-(2-methylpropyl)phenyl]propanoic acid
InChIKey
HEFNNWSXXWATRW-UHFFFAOYSA-N
- Appearance
- White powder, melting at 74 to 77 °C.
- Solubility
- Very slightly soluble in water (under 1 mg/mL) and readily soluble in organic solvents such as ethanol and acetone.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Sold in particle size grades, commonly 25, 38, 50, 70 and 90 microns, and in directly compressible grades. State the grade; it decides how the material flows and compresses.
On the US market
- Reference product
- MotrinNDA 017463
- Approved ANDAs
- 65 with a marketed product
- Approved forms and strengths
- Tablet 100 mg, 200 mg, 300 mg, 400 mg, 600 mg, 800 mg
- Oral suspension 100 mg/5 mL, 200 mg/10 mL
- Capsule 200 mg
- Oral drops 40 mg/mL, 50 mg/1.25 mL
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com